Glucotrack (GCTK) Assets Average (2011 - 2026)
Glucotrack's (GCTK) quarterly Assets Average came in at $4.7 million in Q2 2026, down 52.92% on a YoY basis from $9.9 million in Q2 2025, and down 42.13% quarter-over-quarter from $8.1 million in Q4 2025.
Analysis
Glucotrack (GCTK) Assets Average (2011 - 2026) Analysis & Trends
Glucotrack (GCTK) has reported Assets Average for 16 consecutive years, with $4.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average fell 52.92% year-over-year to $4.7 million; the trailing twelve-month figure through Jun 2026 stood at $4.7 million (down 52.92% YoY), and the FY2025 full-year result was $6.9 million, up 27.06% from the prior year.
- Assets Average declined to $4.7 million in Q2 2026 per GCTK's latest filing, from $8.1 million in the prior quarter.
- Across five years, Assets Average topped out at $9.9 million in Q2 2025 and bottomed at $717000.0 in Q3 2024.
- Historically, Assets Average has averaged $5.1 million across 5 years, with a median of $4.8 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Assets Average sank 91.14% in 2024, then surged 1190.1% in 2025.
- Over 5 years, Assets Average stood at $3.0 million in 2022, then soared by 103.4% to $6.0 million in 2023, then plunged by 44.15% to $3.4 million in 2024, then surged by 138.65% to $8.1 million in 2025, then slumped by 42.13% to $4.7 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $4.7 million, $8.1 million, and $9.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Intuitive Surgical | 127.32 Bn | 122.10 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 93.17 Bn |
| 4 | Stryker | 103.97 Bn | 100.50 Bn | 4.50 Bn | 47.11 Bn |
| 5 | Boston Scientific | 63.66 Bn | 63.12 Bn | 3.85 Bn | 44.78 Bn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | 13.59 Bn |
| 7 | Alcon | 33.00 Bn | 31.54 Bn | 1.68 Bn | 31.36 Bn |
| 8 | Dexcom | 32.04 Bn | 30.09 Bn | 830.00 Mn | 6.54 Bn |
| 9 | Steris | 20.70 Bn | 20.22 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Glucotrack | 1.08 Mn | -45,410.46 | - | 4.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.67 Mn |
| Dec 31, 2025 | 8.06 Mn |
| Sep 30, 2025 | 9.25 Mn |
| Jun 30, 2025 | 9.91 Mn |
| Mar 31, 2025 | 7.77 Mn |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | 717,000.00 |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Dec 31, 2023 | 6.05 Mn |
| Sep 30, 2023 | 8.09 Mn |
| Jun 30, 2023 | 5.12 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 2.97 Mn |
| Sep 30, 2022 | 3.91 Mn |
| Jun 30, 2022 | 4.84 Mn |
| Mar 31, 2022 | 5.81 Mn |
| Dec 31, 2021 | 6.95 Mn |
| Sep 30, 2021 | 8.12 Mn |
| Jun 30, 2021 | 9.12 Mn |